Alaa Refaat
Impact in
- Pharmacology top 5%
- Berberine and alkaloids research
- Alkaloids: synthesis and pharmacology
- Piperaceae Chemical and Biological Studies
-
- Curcumin's Biomedical Applications
Papers in
-
- Cell death mechanisms and regulation 2
-
- Immune Cell Function and Interaction 4
- Galectins and Cancer Biology 3
- T-cell and Retrovirus Studies 3
- Co-authors
- Ikuo Saiki (12 shared papers)Ahmed Abdrabou (2 shared papers)Sherif Abdelhamed (6 shared papers)Hiroaki Sakurai (10 shared papers)Satoru Yokoyama (4 shared papers)Syed Faisal Zaidi (4 shared papers)Toshiro Sugiyama (4 shared papers)Hideo Yagita∥ (2 shared papers)
- Journals
- Helicobacter (2 papers)Journal of Biological Chemistry (2 papers)Molecular Cancer Therapeutics (1 paper)Scientific Reports (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- JapanEgyptUnited Kingdom
In The Last Decade
Alaa Refaat
24 papers receiving 590 citations
Peers
Comparison fields: 5 of 83
- Pharmacology 103
- Molecular Medicine 32
- Cancer Research 88
- Immunology 120
- Pharmacology 91
Countries citing papers authored by Alaa Refaat
This map shows the geographic impact of Alaa Refaat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alaa Refaat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alaa Refaat more than expected).
Fields of papers citing papers by Alaa Refaat
This network shows the impact of papers produced by Alaa Refaat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alaa Refaat. The network helps show where Alaa Refaat may publish in the future.
Co-authors
The 25 scholars most cited alongside Alaa Refaat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 75 | |
| 2 | 2015 | 70 | |
| 3 | Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells. | 2014 | 57 |
| 4 | 2013 | 55 | |
| 5 | 2012 | 41 | |
| 6 | 2009 | 41 | |
| 7 | 2019 | 35 | |
| 8 | 2009 | 30 | |
| 9 | 2011 | 26 | |
| 10 | 2019 | 26 | |
| 11 | 2015 | 22 | |
| 12 | 2018 | 19 | |
| 13 | 2010 | 19 | |
| 14 | 2020 | 14 | |
| 15 | 2015 | 13 | |
| 16 | 2015 | 12 | |
| 17 | 2017 | 12 | |
| 18 | 2017 | 10 | |
| 19 | 2019 | 6 | |
| 20 | 2018 | 5 |
About Alaa Refaat
Alaa Refaat is a scholar working on Molecular Biology, Immunology, Oncology, Surgery and Cancer Research, having authored 24 papers that have together received 598 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Galectins and Cancer Biology (3 papers), HER2/EGFR in Cancer Research (3 papers), T-cell and Retrovirus Studies (3 papers), Animal Disease Management and Epidemiology (2 papers), Cancer-related Molecular Pathways (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Pharmacology (103 citations), Molecular Medicine (32 citations), Cancer Research (88 citations), Immunology (120 citations) and Pharmacology (91 citations). Alaa Refaat has collaborated with scholars based in Japan, Egypt and United Kingdom. Frequent co-authors include Ikuo Saiki, Ahmed Abdrabou, Sherif Abdelhamed, Hiroaki Sakurai, Satoru Yokoyama, Syed Faisal Zaidi, Toshiro Sugiyama, Hideo Yagita∥, Khan Usmanghani and Jibran Sualeh Muhammad. Their work appears in journals such as Helicobacter, Journal of Biological Chemistry, Molecular Cancer Therapeutics, Scientific Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.